EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Phenotypic Models of Drug–Drug‐Gene Interactions Mediated by Cytochrome Drug‐Metabolizing Enzymes

Roberto Viviani iD, Judith Berres iD, Julia C Stingl iD

Clinical Pharmacology & Therapeutics · 2024-09 · 116 (3) · 592-601

DOI: 10.1002/cpt.3188 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 06.02.2024. Verfasst von Roberto Viviani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Psychology, University of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Drug Interactions, Phenotype. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: FWF Austrian Science Fund, German Ministry of Education and Research, Austrian Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic polymorphisms in drug metabolizing enzymes and drug–drug interactions are major sources of inadequate drug exposure and ensuing adverse effects or insufficient responses. The current challenge in assessing drug–drug gene interactions (DDGIs) for the development of precise dose adjustment recommendation systems is to take into account both simultaneously. Here, we analyze the static models of DDGI from in vivo data and focus on the concept of phenoconversion to model inhibition and genetic polymorphisms jointly. These models are applicable to datasets where pharmacokinetic information is missing and are being used in clinical support systems and consensus dose adjustment guidelines. We show that all such models can be handled by the same formal framework, and that models that differ at first sight are all versions of the same linear phenoconversion model. This model includes the linear pharmacogenetic and inhibition models as special cases. We highlight present challenges in this endeavor and the open issues for future research in developing DDGI models for recommendation systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug InteractionsPhenotypeHumansPharmaceutical PreparationsPharmacogeneticsPolymorphism, GeneticCytochrome P-450 Enzyme SystemModels, Biological

Substanzen

Pharmaceutical PreparationsCytochrome P-450 Enzyme System

Autor:innen und Institutionen

  • Institute of Psychology, University of Innsbruck, Innsbruck, Austria.
  • Department of Psychiatry and Psychotherapy III, University of Ulm, Ulm, Germany.
  • Institute of Clinical Pharmacology, University Hospital RWTH Aachen, Aachen, Germany.

ORCID-Profile: Roberto Viviani, Judith Berres, Julia C Stingl

Förderung

  • FWF Austrian Science Fund
  • German Ministry of Education and Research
  • Austrian Science Fund

Zitieren

APA

Viviani, R., Berres, J., & Stingl, J. C. (2024). Phenotypic Models of Drug–Drug‐Gene Interactions Mediated by Cytochrome Drug‐Metabolizing Enzymes. Clinical Pharmacology & Therapeutics, 116(3), 592-601. https://doi.org/10.1002/cpt.3188

Vancouver

Viviani R, Berres J, Stingl JC. Phenotypic Models of Drug–Drug‐Gene Interactions Mediated by Cytochrome Drug‐Metabolizing Enzymes. Clinical Pharmacology & Therapeutics. 2024;116(3):592-601. doi:10.1002/cpt.3188

BibTeX
@article{Viviani2024,
  author = {Viviani, Roberto and Berres, Judith and Stingl, Julia C},
  title = {Phenotypic Models of Drug–Drug‐Gene Interactions Mediated by Cytochrome Drug‐Metabolizing Enzymes},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2024},
  volume = {116},
  number = {3},
  pages = {592--601},
  doi = {10.1002/cpt.3188}
}
Kostenlos starten →